Article Text

Download PDFPDF
Expression of NCAM and OCIAD1 in well-differentiated thyroid carcinoma: correlation with the risk of distant metastasis
  1. An-Hang Yang1,2,
  2. Jui-Yu Chen3,
  3. Chen-Hsen Lee3,4,
  4. Jun-Yi Chen1
  1. 1Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  2. 2Department of Pathology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Province of China
  3. 3Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
  4. 4Department of Surgery, School of Medicine, National Yang-Ming University, Taipei, Taiwan
  1. Correspondence to Professor An-Hang Yang, Rm. 6047, Medical Technology Building, Department of Pathology, Taipei Veterans General Hospital, Taipei 11217, Taiwan, Province of China; ahyang{at}


Aims The biomarkers representing the metastatic potential of well-differentiated thyroid carcinoma remain to be established. A study was undertaken to find whether the expression status of neural cell adhesion molecule (NCAM) and/or ovarian cancer immunoreactive antigen domain containing 1 (OCIAD1) is associated with the metastatic potential of differentiated thyroid carcinoma.

Methods NCAM and OCIAD1 were analysed by immunohistochemistry on tissue microarrays.

Results Among 214 well-differentiated thyroid carcinomas, 68 patients had distant metastases. Immunohistochemical analyses showed that the majority of benign thyroid lesions expressed NCAM while a significant proportion of thyroid carcinomas lost or had reduced NCAM expression. Both follicular and papillary carcinomas with distant metastasis had a significantly higher frequency of preserving NCAM expression. Hierarchical clustering analysis showed that OCIAD1 had significant differential expression between benign and malignant thyroid lesions. The overall metastatic-to-localised tumour ratio was higher in NCAM-expressing clusters, but the difference between ratios of OCIAD1-positive and OCIAD1-negative subclusters was not significant.

Conclusions These analyses suggest that the preservation of NCAM expression in well-differentiated thyroid carcinoma is an indicator for a higher risk of distant metastasis. OCIAD1 is a potential biomarker of thyroid carcinoma but had no significant additive effect on the risk of distant metastasis. Further elucidation of the molecular mechanisms underlying the NCAM-mediated cellular processes will be beneficial for the development of effective treatments against the metastasis of thyroid carcinoma.

  • NCAM
  • CD56
  • OCIAD1
  • thyroid carcinoma
  • distant metastasis
  • surgical pathology
  • nephrology
  • electron microscopy
  • molecular pathology
  • thyroid

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding This work was supported by Taipei Veterans General Hospital (V98C1-047) and the National Science Council (NSC96-2628-B-075-003 and NSC99-2320-B-075-002).

  • Competing interests None.

  • Ethics approval Institutional Review Board, Veterans General Hospital-TAIPEI, Shih-Pai, Taipei, Taiwan.

  • Provenance and peer review Not commissioned; externally peer reviewed.